Megna Michael R's Form 4 filing
Kiniksa Pharmaceuticals International, plc (KNSA) · filed Aug 6, 2025
- Accession no.
- 0001415889-25-021177
- Filed
- Aug 6, 2025
- Trade date
- Jul 15-Aug 4, 2025
- Filing delay
- 22 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $550.0K. It was filed 22 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Megna Michael RCIK 0001464583 | Officer (CHIEF ACCOUNTING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2025 | Class A Ordinary Share | AGrant or awardAcquired | +495 | $15.63 | +$7,736.85 | 33,041 | Direct | |
| Aug 4, 2025 | Class A Ordinary Share | MOption exerciseAcquired | +17,000 | $15.52 | +$263,840 | 50,041 | Direct | |
| Aug 4, 2025 | Class A Ordinary Share | SSaleDisposed | −17,000 | $32.35 | −$549,950 | 33,041 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2025 | Class A Ordinary Share | MOption exerciseDisposed | −17,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.